Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
11,609,560
-
Share change
-
+460,003
-
Total reported value
-
$96,937,885
-
Put/Call ratio
-
33%
-
Price per share
-
$8.35
-
Number of holders
-
78
-
Value change
-
+$6,055,428
-
Number of buys
-
40
-
Number of sells
-
23
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2016
As of 30 Sep 2016,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,609,560 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, BlackRock Fund Advisors, VANGUARD GROUP INC, Opaleye Management Inc., FRANKLIN RESOURCES INC, BlackRock Institutional Trust Company, N.A., Allianz Asset Management GmbH, JPMORGAN CHASE & CO, STATE STREET CORP, and CAM Group Holding A/S.
This page lists
78
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.